SYNTHESIS AND CHARACTERIZATION OF VARIOUS 3-[3,5-BIS (TRIFLUOROMETHYL)PHENYL]-5-(SUBSTITUTED PHENYL)-1,2-ISOXAZOLE
Journal Title: Journal of Atoms and Molecules - Year 2012, Vol 2, Issue 5
Abstract
Some novel heterocyclic compounds containing isoxazole ring systems were prepared from various chalcones. The synthesized compounds have been characterized by elemental analysis and spectral methods
Authors and Affiliations
Tejas Vyas, Kiran Nimavat, Kartik Vyas
Keywords
Related Articles
- EP ID EP367686
- DOI -
- Views 105
- Downloads 0
A NOVEL RP-HPLC METHOD FOR THE QUANTIFICATION OF RUXOLITINIB IN FORMULATIONS
A simple, precise and accurate RP-HPLC method was developed and validated for rapid assay of Ruxolitinib in tablet dosage form. Isocratic elution at a flow rate of 1ml/min was employed on a symmetry Chromosil C18 (250x4....
IMPACT OF VOLLYBALL (TEAM GAME) VERSUS AEROBIC (INDIVIDUAL EXCERCISES) IN THE MITIGATING OF THE DEPRESSION
This study investigated the influence of eight-week volleyball game versus aerobic exercise interventions in mitigating of depression in the young people. The first 51persons from100 participates who had more depression...
ESTIMATION OF SYSTEM RELIABILITY FOR LOG – LOGISTIC DISTRIBUTION
A multicomponent system of k components having strengths following k- independently and identically distributed random variables 1 2 k y , y ,....,y and each component experiencing a random stress X is considered. The sy...
RP – HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ANALYSIS OF CLOBAZAM IN PHARMACEUTICAL DOSAGE FORMS
A simple, precise and accurate RP-HPLC method was developed and validated for rapid assay of clobazamin tablet dosage form. Isocratic elution at a flow rate of 1ml min-1 was employed on a symmetry C18 column at ambient t...
A REVIEW ARTICLE TO DEVELOP SUSTAIN RELEASE RIVAROXABAN FORMULATION
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto.[1] In the United States, it is marketed by Janssen Pharmaceutical.[2] It is the first available...